July 25, 2017 - By Winifred Garcia
Amarin Corporation plc is a biopharmaceutical firm with activities in lipid science focused on the commercialization and development of therapeutics for cardiovascular health. The company has market cap of $1.11 billion. The Firm operates through the development and commercialization of Vascepa segment. It currently has negative earnings. The Company’s lead product, Vascepa capsule, is approved by the United States Food and Drug Administration (FDA) for use as an adjunct to diet to reduce triglyceride levels in adult patients with severe hypertriglyceridemia.
Analysts expect Hanesbrands Inc. (NYSE:HBI) to report $0.53 EPS on August, 1.They anticipate $0.02 EPS change or 3.92% from last quarter’s $0.51 EPS. HBI’s profit would be $195.44 million giving it 10.96 P/E if the $0.53 EPS is correct. After having $0.29 EPS previously, Hanesbrands Inc.’s analysts see 82.76% EPS growth. The stock decreased 1.32% or $0.31 during the last trading session, reaching $23.24. About shares traded. Hanesbrands Inc. (NYSE:HBI) has declined 23.23% since July 25, 2016 and is downtrending. It has underperformed by 39.93% the S&P500.
Among 17 analysts covering Hanesbrands (NYSE:HBI), 13 have Buy rating, 0 Sell and 4 Hold. Therefore 76% are positive. Hanesbrands had 29 analyst reports since September 17, 2015 according to SRatingsIntel. The company was maintained on Friday, February 3 by UBS. DA Davidson upgraded the stock to “Buy” rating in Monday, December 12 report. The rating was reinitiated by Wells Fargo with “Outperform” on Thursday, October 22. The rating was downgraded by Morgan Stanley on Monday, February 27 to “Equal-Weight”. Brean Capital initiated the stock with “Buy” rating in Monday, July 17 report. The rating was downgraded by Cowen & Co to “Market Perform” on Wednesday, October 12. Oppenheimer initiated the shares of HBI in report on Friday, October 16 with “Outperform” rating. On Monday, January 11 the stock rating was upgraded by Nomura to “Buy”. The rating was maintained by UBS with “Buy” on Friday, February 5. Buckingham Research reinitiated it with “Buy” rating and $30 target in Monday, July 17 report.
Hanesbrands Inc. is a marketer of basic innerwear and activewear apparel in the Americas, Europe, Australia and Asia/Pacific under apparel brands, such as Hanes, Champion, Maidenform, DIM, Bali, Playtex, Bonds, JMS/Just My Size, Nur Die/Nur Der, L’eggs, Lovable, Wonderbra, Flexees, Gear for Sports and Berlei. The company has market cap of $8.57 billion. The Firm operates through four divisions: Innerwear, Activewear, Direct to Consumer and International. It has a 16.73 P/E ratio. The Innerwear segment focuses on core apparel products, such as intimate apparel, men’s underwear, women’s panties, children’s underwear, socks and hosiery.
Investors sentiment increased to 1.21 in 2016 Q4. Its up 0.21, from 1 in 2016Q3. It is positive, as 53 investors sold Hanesbrands Inc. shares while 167 reduced holdings. 84 funds opened positions while 182 raised stakes. 327.85 million shares or 4.08% less from 341.78 million shares in 2016Q3 were reported. Grt Ptnrs Limited Liability Company stated it has 10,000 shares or 0.06% of all its holdings. Shell Asset Management has 0.02% invested in Hanesbrands Inc. (NYSE:HBI) for 25,960 shares. Trexquant Inv Limited Partnership has invested 0.34% of its portfolio in Hanesbrands Inc. (NYSE:HBI). Blackrock Grp Limited holds 3.02M shares or 0.03% of its portfolio. Selway Asset reported 120,650 shares or 1.56% of all its holdings. California Pub Employees Retirement Sys has 0.03% invested in Hanesbrands Inc. (NYSE:HBI). Bb&T Secs invested in 247,693 shares or 0.09% of the stock. Spot Trading Ltd Liability Corp invested in 62,211 shares. Petrus Trust Lta holds 0.07% of its portfolio in Hanesbrands Inc. (NYSE:HBI) for 12,291 shares. Next Group reported 664 shares. Citigroup Incorporated reported 26,944 shares. 1.05M were accumulated by Swiss Retail Bank. Envestnet Asset Inc holds 183,548 shares. Blackrock Advsr Limited Liability Corp has invested 0.01% of its portfolio in Hanesbrands Inc. (NYSE:HBI). Northwestern Mutual Wealth Management holds 0.01% or 30,192 shares.
Since March 10, 2017, it had 1 insider buy, and 4 sales for $3.18 million activity. The insider Evans Gerald sold $831,329. Another trade for 5,000 shares valued at $99,594 was bought by NELSON RONALD L. Marsh John T. had sold 11,100 shares worth $250,527 on Tuesday, June 13. Upchurch W Howard Jr also sold $1.28 million worth of Hanesbrands Inc. (NYSE:HBI) on Wednesday, June 14.
The stock decreased 0.96% or $0.04 during the last trading session, reaching $4.12. About shares traded. Amarin Corporation plc (ADR) (AMRN) has risen 76.19% since July 25, 2016 and is uptrending. It has outperformed by 59.49% the S&P500.
Consonance Capital Management Lp holds 8.47% of its portfolio in Amarin Corporation plc (ADR) for 25.05 million shares. Oracle Investment Management Inc owns 7.94 million shares or 4.05% of their US portfolio. Moreover, Healthcare Value Capital Llc has 1.48% invested in the company for 450,000 shares. The Maryland-based Rock Springs Capital Management Lp has invested 1.03% in the stock. Broadfin Capital Llc, a New York-based fund reported 2.83 million shares.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our daily email newsletter.